Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 231 participants.
Also called NCT02294539
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 231 participants
- Registry
-
NCT02294539
-
- Other papers using this trial's data
- Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02294539. Randomized; double masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-05-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
- Condition
- Hypertension
- Intervention (Drug)
- Losartan 50mg/amlodipine 5mg
- Intervention (Drug)
- Losartan 100mg/amlodipine 5mg
- Intervention (Drug)
- Losartan 50mg/Hydrochlorothiazide 12.5mg
- Intervention (Drug)
- Losartan 100mg/Hydrochlorothiazide 25mg
- Lead sponsor
- Chong-Jin Kim
- Collaborator
- Hanmi Pharmaceutical Company Limited
Record details
- Record id
cardio:ct-nct02294539- Content hash
2bd98e6f1952002297222a8f7155cb921d0ebff2a6e0232375afc8ccac397e3a